Kirolos Meilika

Icahn School of Medicine at Mount Sinai

Papers

4

Total Citations

84

H-Index

4

About

Kirolos Meilika is a pioneering urologic surgeon and researcher whose work is reshaping the surgical management of kidney cancer. His primary research focus lies in the advancement of robotic-assisted surgery, particularly the emerging field of single-port (SP) technology. Meilika’s most impactful contribution is his leadership within the Single Port Advanced Research Consortium (SPARC), where his landmark 2022 study (53 citations) provided the first rigorous, propensity-matched comparison demonstrating that single-port robotic partial nephrectomy is a safe and effective alternative to traditional multi-port approaches. Beyond technology adoption, he has challenged long-standing clinical dogma; his 2020 study (16 citations) on drain placement after robotic partial nephrectomy provided critical evidence supporting a nonroutine drain approach, reducing unnecessary interventions without compromising patient safety. His work also extends to population-level analyses of kidney cancer treatment trends and the complex outcomes of salvage robotic surgery. Through these contributions, Meilika is not only refining surgical techniques but also establishing new, evidence-based standards of care that prioritize both oncologic efficacy and patient recovery.

Research Focus

Key Achievements

4
H-Index
4
Papers
84
Total Citations
21
Avg Citations/Paper
🏆 Most Cited Paper
A Propensity-Matched Comparison of the Perioperative Outcomes Between Single-Port and Multi-Port Robotic Assisted Partial Nephrectomy: A Report from the Single Port Advanced Research Consortium (SPARC)
53 citations · 2022
📈 Most Prolific Year: 2023 (2 Papers)
🤝 Key Collaborators: 29
🏛 Institutions: Icahn School of Medicine at Mount Sinai

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago